Operator: Good day, and welcome to the Aethlon Medical Third Quarter Fiscal 2025 Earnings and Corporate Update Call. All ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...

How does Mary view her own clinical progress? Assess the problem ... As you and Mary carry out this plan, you note that it seems to be helping her to stay organized. By the end of the week ...

The field of chronic disease management is witnessing a significant transformation due to recent advancements in big data analytics and artificial ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

Two experts have been hand-picked by the federal government to travel the country for six months to gather harrowing stories of bullying as the government forges ahead with its plan to create a ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

The clinical practice update offers 12 “best practice advice” statements on POEM to treat achalasia and other esophageal ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...

Electronic patient-reported outcomes improved clinical outcomes, the patient experience and service utilization among cancer patients, according to a study published Feb. 7 in Nature Medicine . Here ...

Progress in AI feeds into related areas, too, such as clinical diagnostics and medical devices. Trials can be decentralised and data gathered remotely, with more patient input overall into the ...